Cargando…
SAT-329 Novel Dehydroepiandrosterone Derivatives Inhibiting Metastatic Prostate Cancer Cell Proliferation
Abstract: Metastatic prostate tumor cells mainly express type 1 5α-reductase and have been linked to antiandrogenic resistant prostate cancers. However, the isozyme of type 2 5α-reductase is mostly expressed in normal prostate epithelial cells and non-metastatic cancer cells of the prostate. Therefo...
Autores principales: | Cabeza, Marisa, Bautista, Lucero, Heuze, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552093/ http://dx.doi.org/10.1210/js.2019-SAT-329 |
Ejemplares similares
-
SAT-318 A Case of Metastatic Paraganglioma
por: Mohammadi, Manijeh, et al.
Publicado: (2019) -
SAT059 Metastatic Insulinoma Diagnosed Postpartum
por: Faber, Alexis, et al.
Publicado: (2023) -
SAT-328 Androgens Modulate the Expression of Prostatic Acid Phosphatase
por: Izadmehr, Sudeh, et al.
Publicado: (2019) -
SAT-132 The Secretory Vesicle Membrane Protein, CYB561, Promotes the Growth and Metastatic Potential of Castration-Resistant Neuroendocrine Prostate Cancer
por: Olarte, Kevin Christian V, et al.
Publicado: (2020) -
MON-329 Calcitonin-Secreting Neuroendocrine Tumor Raising Concern for Medullary Thyroid Carcinoma in a Patient with Thyroid Nodules
por: Del Castillo, Ma. Dolores, et al.
Publicado: (2019)